Identification of Laylaa 28:
No description |
Search images on Google Product Monograph
Active Ingredients:
- levonorgestrel, 0.1 MG
- ethinyl estradiol, 0.02 MG
DIN: 02424290
Dosage Form(s): TABLET
Route(s) of Administration: ORAL
Description: 28 DAYS
Schedule: Prescription
Company: LUPIN PHARMA CANADA LIMITED
ATC:
- G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM (ATC, WHO, Wiki)
- G03A - HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE (ATC, WHO)
- G03AA - Progestogens and estrogens, fixed combinations (ATC, WHO)
- G03AA07 - LEVONORGESTREL AND ESTROGEN (WHO)
Pharmaceutical standard: MFR